Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials. Grayling MJ, McMenamin M, Chandler R, Heer R, et al. BMC Cancer 2022;22:111.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Grayling MJ, McMenamin M, Chandler R, Heer R, et al. Improving power in PSA response analyses of metastatic castration-resistant prostate cancer trials. BMC Cancer 2022;22:111.
PMID: 35081926